183 related articles for article (PubMed ID: 15008870)
1. Immunostaining melanoma frozen sections: the 1-hour protocol.
Bricca GM; Brodland DG; Zitelli JA
Dermatol Surg; 2004 Mar; 30(3):403-8. PubMed ID: 15008870
[TBL] [Abstract][Full Text] [Related]
2. Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor.
Glass LF; Raziano RM; Clark GS; Higgins HW; Ladd S; Lien MH; Chen R; Cherpelis BS
Am J Dermatopathol; 2010 Jun; 32(4):319-25. PubMed ID: 20514666
[TBL] [Abstract][Full Text] [Related]
3. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol.
Cherpelis BS; Moore R; Ladd S; Chen R; Glass LF
Dermatol Surg; 2009 Feb; 35(2):207-13. PubMed ID: 19215257
[TBL] [Abstract][Full Text] [Related]
4. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections.
Kimyai-Asadi A; Ayala GB; Goldberg LH; Vujevich J; Jih MH
Dermatol Surg; 2008 Apr; 34(4):498-500. PubMed ID: 18248466
[TBL] [Abstract][Full Text] [Related]
5. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
6. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
[TBL] [Abstract][Full Text] [Related]
7. Permanent section margin concordance after Mohs micrographic surgery with immunohistochemistry for invasive melanoma and melanoma in situ: A retrospective dual-center analysis.
Young JN; Nguyen TA; Freeman SC; Hill E; Johnson M; Gharavi N; Bar A; Leitenberger J
J Am Acad Dermatol; 2023 May; 88(5):1060-1065. PubMed ID: 36720365
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1.
Kelley LC; Starkus L
J Am Acad Dermatol; 2002 Jan; 46(1):78-84. PubMed ID: 11756950
[TBL] [Abstract][Full Text] [Related]
9. Novel 16-minute technique for evaluating melanoma resection margins during Mohs surgery.
Chang KH; Finn DT; Lee D; Bhawan J; Dallal GE; Rogers GS
J Am Acad Dermatol; 2011 Jan; 64(1):107-12. PubMed ID: 21167405
[TBL] [Abstract][Full Text] [Related]
10. Mohs micrographic surgery for the treatment of melanoma.
Hui AM; Jacobson M; Markowitz O; Brooks NA; Siegel DM
Dermatol Clin; 2012 Jul; 30(3):503-15. PubMed ID: 22800554
[TBL] [Abstract][Full Text] [Related]
11. Use of a novel 1-hour protocol for rapid frozen section immunocytochemistry, in a case of squamous cell carcinoma treated with Mohs micrographic surgery.
Sinha K; Ali F; Orchard G; Rickaby W; Shams M; Mallipeddi R; Patalay R
Clin Exp Dermatol; 2018 Jun; 43(4):454-457. PubMed ID: 29396855
[TBL] [Abstract][Full Text] [Related]
12. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.
Etzkorn JR; Jew OS; Shin TM; Sobanko JF; Neal DE; Miller CJ
J Am Acad Dermatol; 2018 Dec; 79(6):1109-1116.e1. PubMed ID: 30003986
[TBL] [Abstract][Full Text] [Related]
13. A novel 2-hour method for rapid preparation of permanent paraffin sections when treating melanoma in situ with mohs micrographic surgery.
Mallipeddi R; Stark J; Xie XJ; Matthews M; Taylor RS
Dermatol Surg; 2008 Nov; 34(11):1520-6. PubMed ID: 18811716
[TBL] [Abstract][Full Text] [Related]
14. An Update and Review of Clinical Outcomes Using Immunohistochemical Stains in Mohs Micrographic Surgery for Melanoma.
Elgash M; Young J; White K; Leitenberger J; Bar A
Dermatol Surg; 2024 Jan; 50(1):9-15. PubMed ID: 37738278
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections.
Cohen LM; McCall MW; Hodge SJ; Freedman JD; Callen JP; Zax RH
Cancer; 1994 Jun; 73(12):2964-70. PubMed ID: 8199993
[TBL] [Abstract][Full Text] [Related]
16. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery.
Bienert TN; Trotter MJ; Arlette JP
J Cutan Med Surg; 2003; 7(1):25-30. PubMed ID: 12447624
[TBL] [Abstract][Full Text] [Related]
18. Comparison of MITF and Melan-A Immunohistochemistry During Mohs Surgery for Lentigo Maligna-Type Melanoma In Situ and Lentigo Maligna Melanoma.
Christensen KN; Hochwalt PC; Hocker TL; Roenigk RK; Brewer JD; Baum CL; Otley CC; Arpey CJ
Dermatol Surg; 2016 Feb; 42(2):167-75. PubMed ID: 26771682
[TBL] [Abstract][Full Text] [Related]
19. Mohs micrographic surgery for the treatment of malignant melanoma.
Whalen J; Leone D
Clin Dermatol; 2009; 27(6):597-602. PubMed ID: 19880047
[TBL] [Abstract][Full Text] [Related]
20. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma.
Menaker GM; Chiang JK; Tabila B; Moy RL
J Am Acad Dermatol; 2001 May; 44(5):833-6. PubMed ID: 11312433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
